Outlook of 2022 for the healthcare sector, Health News, ET HealthWorld
By Vijender Singh The advent of the pandemic brought about a breakthrough moment for the healthcare sector. There came a dire need to dig beneath the surface to identify gaps…
By Vijender Singh The advent of the pandemic brought about a breakthrough moment for the healthcare sector. There came a dire need to dig beneath the surface to identify gaps…
NEW DELHI: All mild and asymptomatic Covid-19 patients, including those infected with Omicron variant of SARS-CoV2, can now isolate at home, the government said in its revised guidelines for home…
Pfizer may offer its Covid antiviral drug Paxlovid at lower prices for low and middle income countries (LMICs), including India, as an interim measure as the cheaper generic versions may…
PUNE: The SARS-CoV-2’s C.36.3.1 variant carrying Omicron-like genetic variation has been identified for the first time in India, a senior scientist of the Indian Council of Medical Research (ICMR) told…
The Tata Medical and Diagnostics has developed a kit ‘OmiSure’ that can detect the Omicron variant of SARS-CoV2 in nasopharyngeal/oropharyngeal specimens during the RT-PCR tests, a senior company executive said…
There is uncertainty over the availability in India of Pfizer’s antiviral drug Paxlovid and GSK’s monoclonal antibody Sotrovimab (sold under the brand name Xevudy) – two therapies that appear to…
Washington: A team of US researchers has explored the success behind the new mRNA vaccine technology used by Pfizer and Moderna to make vaccines against Covid. The vaccines have arguably…
Mumbai: As countries try to bend the surging Omicron cases, which is considered to be three times more transmissible than the Delta variant, Molnupiravir the oral antiviral treatment for COVID-19…
by Sudarshan JainThe pandemic continues to be a challenging humanitarian crisis globally with the Omicron variant sparking new fears. With the population facing a risk to their lives and livelihood,…
New York : Pfizer Inc. inks an additional agreement with the United Kingdom (UK) Government to supply an additional 2.5 million treatment courses of its investigational candidate Paxlovid (nirmatrelvir [PF-07321332]…